Latest Breaking News On - Gynecology reproductive sciences - Page 1 : comparemela.com

Predictive Oncology Announces Positive Results From Ovarian Cancer Study With UPMC Magee-Womens Hospital To Be Presented At The 2024 American Society ...

Study successfully demonstrated Predictive s ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer

Intrahepatic Cholestasis of Pregnancy (ICP): Research Into Life-saving Diagnostics Receives Funding

Standard mass spectrometry testing for intrahepatic cholestasis of pregnancy (ICP) can take days, which is sometimes too late. A newer assay can provide test

AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer | Company Announcement

Investegate announcements from AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer

AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer

OCALA, Fla., April 10, 2024 AIM ImmunoTech Inc.   today announced top-line interim data indicating that combining Ampligen with Keytruda in the treatment of recurrent ovarian cancer may have.

AIM ImmunoTech (AIM) Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer